874 resultados para Unlicensed medicines
Resumo:
Presently, the dying process and death most often occur in hospitals and, particularly, in Intensive Care Units (ICU), where patients’ lives are prolonged thanks to advanced technological devices and highly efficient medicines. To learn about the opinion of health care professionals working at a Pediatric Intensive Care Unit in relation to the dying process and dying. This is a descriptive quantitative study. A questionnaire was applied to the unit’s staff members from June to August, 2011. Data were statistically analyzed. Twenty-five professionals answered the questionnaire, and 72% faced death as a natural life process. 60% felt compassion, but that feeling did not interfere with how they cared for patients. Concerning their professional training, 52% reported not to have received any concerning patients’ caregivers in the dying process or death; therefore, they experienced such situation when they were already working, and 76% reported to be interested in updating courses on that theme. Further discussion about this topic during academic education is necessary. It is also necessary to provide health care professionals with specialization courses, debates and experience exchange so that they can better understand and deal with their feelings and limitations in face of death and thus give better care to patients and relate to patients’ families during the dying process of a loved one
Resumo:
Osteosarcoma is the primary osseous neoplasia frequently diagnosed in dogs and it’s the main answerable for more than 85% of the neoplasias origened from the skeleton. The average age of onset of the lesion is 7 years, especially in large breeds and giant, with males being more affected than females. In general, 75% of osteosarcomas develop in the appendicular skeleton and 25% in the axial. The forelimbs are more affected than the hindlimbs, since support 60% of body weight. The osteosarcoma diagnosis is made by the analys of the animal’s clinic historic, detailed physique exams, blood exams alkaline phosphatase, xray exams, cytology, biopsy. The treatment of choice is the amputation associated to the chemotherapy. However, in some cases the member is preserved by the allograft technic. The chemotherapy associated to the surgery reduces the total load of the tumor, lengthens the interval of the life and improves the quality of pacient’s life. The most used medicines are cisplatin and doxorubicin. They can be used in separated or associated ways. The prognostic of dogs with osteosarcoma is reserved
Resumo:
Evaluation of predictive factors for oxidative stress in healthy people. This study aimed to evaluate the inÀuence of factors such as smoNing, alcohol consumption, use of medicines, contact Zith chemicals, as Zell as age and gender on marNers of oxidative stress, in healthy subMects. :e checNed the effect of age on the antioxidant capacity, Zith decreased values in older individuals, Zhich may be the cause of increased oxidative stress, associated Zith aging. Regarding the other factors, no differences Zere found in the values of the marNer of lipid peroxidation and the antioxidant capacity.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
This work deals with present and discuss mainly the chemical composition and pharmacological activities of each species of the National List of Medicinal plants of interest to SUS (RENISUS) contained in scientific articles that are found in the Bauru-SP region. Such information compiled in this study may help in the advancement of scientific research, promoting the speed in bibliographic queries these species. In the present work was carried out consultation papers and described in the form of literature review, published information of the species listed in Renisus specific to the Bauru-SP region are: Aloe spp* (A. vera or A. barbadensis), Schinus terebinthifolius = mastic Schinus, trimera Baccharis, Mikania spp* (M. glomerata and M. laevigata), Vernonia condensata, Tabebuia avellanedeae, Chenopodium ambrosioides, Momordica charantia, Phyllanthus spp* (P. amarus, P. niruri, P. tenellus and P. urinaria), Stryphnodendron adstringens = Stryphnodendron barbatimam, pulegium Mentha, Mentha spp* (M. crispa, M. piperita or M. villosa), Plectranthus barbatus = Coleus barbatus, Persea spp* (gratissima or P. americana P.), Bauhinia spp* (B. affinis, B. forficata or B. variegata), Copaifera spp*, Morus sp*, Eugenia uniflora or brasiliana Myrtus*, Psidium guajava, Syzygium spp* (S. jambolanum or S. cumini), Passiflora spp* (P. alata, P. edulis or P. incarnata), Punica granatum and Casearia sylvestris. Studies have shown that the use of plants as alternatives treatment and sustainable use of Brazilian biodiversity has a breakthrough in research regarding the chemical composition of each species of RENISUS relationship. Many phytochemical studies are reported compiled with possible pharmacological indications of each species. Thus enabling the use and production of herbal medicines in SUS
Resumo:
This study objective was to review a selection of publications on the treatment of benign and malignant tumors with the use of natural medicines obtained from terrestrial and marine flora, both for use in chemotherapy and photodynamic therapy. There are many medications already being used for this purpose and many are still being tested in vivo and in vitro, but all with great future prospects for inclusion in the market
Resumo:
Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999
Resumo:
Pós-graduação em Educação - IBRC
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)